Dopamine and cyclic AMP-regulated phosphoprotein-32 phosphorylation pattern in cocaine and morphine-sensitized rats

Journal of Neurochemistry

Volumn 90, Issue 4, 2004, Pages 792-799

  Scheggi, S ^a   Rauggi, R ^a   Gambarana, C ^a   Tagliamonte, A ^a   De Montis, M G ^a,b,c  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c Department of Neuroscience ^*  (Italy)

Author keywords

Caudate putamen; Dopaminergic D1 receptors; Drugs of abuse; Nucleus accumbens; Protein kinase A activity

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; COCAINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMATE RECEPTOR 1; MORPHINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOPROTEIN DARPP 32; THREONINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; ENZYME ACTIVITY; ENZYME SUBSTRATE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PUTAMEN; RAT; SENSITIZATION; SIGNAL TRANSDUCTION;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; MALE; MORPHINE; MORPHINE DEPENDENCE; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

ANIMALIA;

EID: 4143116675     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02510.x     Document Type: Article

References (34)

1. Bibb J. A., Snyder. G. L., Nishi A. et al. (1999) Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402, 669-671.
2. Bibb J. A., Chen J., Taylor J. R. et al. (2001) Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410, 376-379.
3. Cadoni C. and Di Chiara G. (1999) Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience 90, 447-455.
4. Capper-Loup C., Canales J. J., Kadaba N. and Graybiel A. M. (2002) Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J. Neurosci. 22, 6218-6227.
5. Childers S. R. (1991) Opioid receptor-coupled second messenger systems. Life Sci. 48, 1991-2003.
6. Creese I. and Iversen S. D. (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83, 419-436.
7. Del Rosario C. N., Pacchioni A. M. and Cancela L. M. (2002) Influence of acute or repeated restraint stress on morphine-induced locomotion: involvement of dopamine, opioid and glutamate receptors. Behav. Brain. Res. 134, 229-238.
8. Gambarana C., Ghiglieri O., De Montis M. G. and Tagliamonte A. (1998) Under continuous dizocilpine infusion an N-methyl-D-aspartate receptor independent form of cocaine sensitization develops in rats. Behav. Pharmacol. 9, 61-68.
9. Hemmings H. C. Jr, Greengard P., Tung H. Y. and Cohen P. (1984) DARPP-32, a dopamine regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310, 503-505.
10. Hope B. T., Kosofsky B., Hyman S. E. and Nestler E. J. (1992) Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl Acad. Sci. USA 89, 5764-5768.
11. Hope B. T., Nye H. E. and Kelz M. B. (1994) Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13, 1235-1244.
12. Jeziorski M. and White F. (1995) Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur J. Pharmacol. 275, 235-244.
13. Kalivas P. W. and Stewart J. (1991) Dopamine transmission in drug- and stress-induced behavioral sensitization. Brain Res. Rev. 16, 223-244.
14. King M. M., Huang C. Y., Chock P. B., Nairn A. C., Hemmings H. C. Jr, Chan K.-F. J. and Greengard P. (1984) Mammalian brain phosphoproteins as substrates for calcineurin. J. Biol. Chem. 259, 8080-8083.
15. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
16. Nestby P., Schotte A., Janssen P. F. M., Tjon G. H. K., Vanderschuren L. J. M. J., De Vries T. J., Mulder A. H., Leysen J. E. and Schoffelmeer A. N. M. (1997) Striatal dopamine receptors in rats displaying long-term behavioural sensitization to morphine. Synapse 27, 262-265.
17. Nestler E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128.
18. Nishi A., Bibb J. A., Snyder G. L., Higashi H., Naim A. C. and Greengard P. (2000) Amplification of dopaminergic signaling by a positive feedback loop. Proc. Natl Acad. Sci. USA 16, 8147-8155.
19. Nye H. E. and Nestler E. J. (1996) Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49, 636-645.
20. Ouimet C. C., Miller P. E., Hemmings H. C. Jr, Walaas S. I. and Greengard P. (1984) DARPP-32, a dopamine- and adenosine 3′5′ monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4, 114-124.
21. Paulson P. E., Camp D. M. and Robinson D. E. (1991) Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 103, 480-492.
22. Piepponen T. P., Katajamaki J., Kivastik T., Zharkovsky A. and Ahtee L. (1996) Behavioural and neurochemical sensitization of morphine-withdrawn rats to quinpirole. Pharmacol. Biochem. Behav. 54, 787-792.
23. Pollock J. and Kornetsky C. (1989) Evidence for the role of dopamine D1 receptors in morphine induced stereotypic behavior. Neurosci. Lett. 102, 291-296.
24. Pollock J. and Kornetsky C. (1996) Reexpression of morphine-induced oral stereotypy six months after last morphine sensitizing dose. Pharmacol. Biochem. Behav. 53, 67-71.
25. Robinson T. E. and Becker J. B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396, 157-198.
26. Scheggi S., Masi F., Tagliamonte A., Gambarana C., Tolu P. and De Montis M. G. (2000) Rats sensitized to morphine are resistant to the behavioral effect of an unavoidable stress. Brain Res. 853, 290-298.
27. Self D. W. and Nestler E. J. (1995) Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18, 463-495.
28. Smart D., Smith G. and Lambert D. G. (1994) μ-Opioid receptor stimulation of inositol (1,4,5) trisphosphate formation via a pertussis toxin sensitive G protein. J. Neurochem. 62, 1009-1014.
29. Snyder G. L., Allen P. B., Fienberg A. A., Valle C. G., Huganir R. L., Naim A. C. and Greengard P. (2000) Regulation of phosphorylation of the GLURI AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J. Neurosci. 20, 4480-4488.
30. Stoof J. C. and Kebabian J. W. (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294, 366-368.
31. Tingley W. G., Roche K. W., Thompson A. K. and Huganir R. L. (1993) Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature 364, 70-73.
32. Van Vliet B. J., Rijswijk G., Wardeh G., Mulder A. H. and Schoffelmeer A. N. M. (1993) Adaptive changes in the number of Gs and Gi-proteins underlie adenylate cyclase sensitization in morphine-treated rat striatal neurons. Eur. J. Pharmacol. Mol. Pharmacol. 245, 23-29.
33. Viganò D., Rubino T., Di Chiara G., Ascari I., Massi P. and Parolaro D. (2003) μ-Opioid receptor signaling in morphine sensitization. Neuroscience 117, 921-929.
34. Walaas S. I., Aswad D. W. and Greengard P. (1983) A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 301, 69-71.